98%
921
2 minutes
20
Phosphopantetheine adenylyltransferase (PPAT) catalyzes the penultimate step of coenzyme A (CoA) biosynthesis pathway by transferring the adenylyl group from adenosine triphosphate (ATP) to 4'-phosphopantetheine (PNS), yielding 3'-dephosphocoenzyme A and pyrophosphate. In this study, the recombinant PPAT from Enterobacter spp. strain 638 (EbPPAT) was purified and co-crystallized with phosphonoacetic acid (PAE). The structure showed the presence of three homodimers AB, CD, and EF in the asymmetric unit. The 14 extra N-terminal residues (Met-14 to Ser-1, 14-mer peptide) from the expression tag were observed in Molecules B and F. These tag-peptides occupied the PNS-binding sites of adjacent Molecules A and E, respectively. Additionally, a heptapeptide (Met-14 to Gly-8) was also observed in the PNS-binding site of Molecule C. Furthermore, two PAE molecules were present in the ATP-binding sites of Molecules B, D, and F, whereas a single PAE molecule was found in Molecules A, C, and E. This showed that tag-peptides blocked the PNS-binding site while PAE blocked the ATP-binding sites. Three peptides of the tag, including 14-mer (Met-14 to Ser-1), heptapeptide (Met-14 to Gly-8) and pentapeptide (Met-14 to Thr-10) were synthesized, and their binding affinities were estimated, which showed the K values of 5.5 × 10, 1.8 × 10, and 7.3 × 10 M, respectively. PAE molecules bound to EbPPAT in the ATP-binding sites with a K of 4.77 × 10 M. This is the first structure of PPAT with peptides bound in the substrate-binding sites, indicating a novel approach to design peptide inhibitors.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12278691 | PMC |
http://dx.doi.org/10.1002/pro.70216 | DOI Listing |
J Chem Inf Model
August 2025
National Institute of Chemistry, Hajdrihova 19, 1000, Ljubljana, Slovenia.
Water-based pharmacophore modeling is an emerging approach in inhibitor design that leverages the dynamics of explicit water molecules within ligand-free, water-filled binding sites to derive 3D pharmacophores for virtual screening. In this study, we assess the potential of this strategy through a case study targeting the ATP binding sites of Fyn and Lyn protein kinases─members of the Src family that have been less explored in anticancer drug discovery compared to other family members. Molecular dynamics simulations of multiple kinase structures were used to generate and validate several water-derived pharmacophores, which were subsequently employed to screen chemically diverse libraries of compounds.
View Article and Find Full Text PDFNucleic Acids Res
August 2025
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan 115, Republic of China.
The DExD/H-box RNA helicase Prp22 catalyzes messenger RNA (mRNA) release from the spliceosome, and has also been implicated in proofreading the 3' splice site (3'SS), preventing exon ligation of mutant pre-mRNAs through an ATP-dependent mechanism. However, here we reveal an unexpected role for Prp22 in promoting exon ligation of both wild-type and mutant pre-mRNAs by stabilizing Slu7's association with the spliceosome prior to exon ligation. Notably, ATP binding, rather than hydrolysis, by Prp22 inhibits exon ligation of 3'SS mutant pre-mRNA.
View Article and Find Full Text PDFInt J Mol Sci
August 2025
Department of Pharmaceutical and Biomedical Science, University of Georgia, Athens, GA 30602, USA.
P-glycoprotein (Pgp) plays a significant role in the disposition of cardiac glycoside (CG) drugs across the cell membrane. The relatively narrow therapeutic indices of these drugs, coupled with the co-administration of drugs that inhibit Pgp's transport mechanism, often cause an increased level of CG in the patient's plasma, resulting in fatal arrhythmia. Therefore, understanding the underlying mechanism of the CG-Pgp interaction is necessary to circumvent Pgp-mediated transport and effectively design next-generation CGs.
View Article and Find Full Text PDFAmino Acids
August 2025
Department of Thoracic Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qing Chun Road, Hangzhou, 310000, China.
ABCA1 is a key protein in maintaining cholesterol homeostasis, and its abnormal expression is associated with the progression of many cancers. Nonetheless, the specific molecular mechanisms by which ABCA1 facilitates the development of LUAD remain largely unexplored, necessitating further in-depth investigation. The TCGA-LUAD database was used to analyze the expression of ABCA1 in LUAD tissues.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
August 2025
Molecular Science and Biomedicine Laboratory, State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, Hunan 410082, China.
DNA aptamers that bind small molecules with high affinity have revolutionized the fields of biosensing and bioimaging. Recently, a DNA aptamer named 1301b has been identified as the most potent DNA aptamer for the binding of adenosine triphosphate (ATP) with a dissociation constant () of ~2.7 µM.
View Article and Find Full Text PDF